Unknown

Dataset Information

0

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.


ABSTRACT: The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput x-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (Mpro), which is essential for viral replication. In contrast to commonly applied x-ray fragment screening experiments with molecules of low complexity, our screen tested already-approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to Mpro In subsequent cell-based viral reduction assays, one peptidomimetic and six nonpeptidic compounds showed antiviral activity at nontoxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2.

SUBMITTER: Gunther S 

PROVIDER: S-EPMC8224385 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9572942 | biostudies-literature
| S-EPMC9272661 | biostudies-literature
| S-EPMC7537881 | biostudies-literature
| S-EPMC7127417 | biostudies-literature
| S-EPMC7961382 | biostudies-literature
| S-EPMC7316061 | biostudies-literature
| S-EPMC9871955 | biostudies-literature
| S-EPMC7724992 | biostudies-literature
| S-EPMC9288249 | biostudies-literature
| S-EPMC7550866 | biostudies-literature